Levocetrimin-M Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, formulated for the management of allergic conditions. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, rhinorrhea, nasal itching, and urticaria associated with allergic rhinitis and chronic idiopathic urticaria. Montelukast, a leukotriene receptor antagonist, blocks the cysteinyl leukotriene receptor, mitigating bronchoconstriction, inflammation, and mucus production commonly observed in asthma and allergic rhinitis. The synergistic action of these agents provides comprehensive relief from allergic symptoms by targeting multiple inflammatory pathways. Levocetrimin-M is indicated for the treatment of seasonal and perennial allergic rhinitis, chronic idiopathic urticaria, and as an adjunct therapy in asthma management to improve pulmonary function and reduce exacerbations. The tablet is generally well tolerated; common adverse effects may include headache, fatigue, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision in pregnant or lactating women. Levocetrimin-M offers an effective therapeutic option for patients requiring combined antihistaminic and leukotriene receptor antagonist therapy for allergic disorders.

Dosage & How to Use